Management and survival of female breast cancer: results of a national survey by the American College of Surgeons
- PMID: 7388735
- DOI: 10.1002/1097-0142(19800615)45:12<2917::aid-cncr2820451203>3.0.co;2-m
Management and survival of female breast cancer: results of a national survey by the American College of Surgeons
Abstract
This is a resume of a Breast Cancer Survey carried out by the American College of Surgeons in 1978. Four hundred and ninety-eight hospitals in 47 states, Washington, D.C., and Puerto Rico participated, contributing a total of 24,136 female patients with histologically confirmed breast cancer. In these patients, five-year cure rates were 60.5% for clinically localized disease and 33.9% for regional disease. Five-year survival rates were 72.8% for localized disease and 49.1% for regional disease. From the 1960's into the early 1970's, there was a gradual shift away from radical mastectomy towards so-called modified radical mastectomy. In a group of patients treated by either radical or modified mastectomies, the axillary nodal status, size of the tumor, and location of the tumor were examined in relation to the prognosis. In the study of number of metastatic nodes in the axilla, there were reduced cure and survival rates in patients with one or more positive nodes as compared to those with negative axillary nodes. With the increase in the number of positive nodes, there was a continuing associated decline in survival and cure. The clinical size of the tumor also correlated well to the prognosis. With the increase in the size of the tumor, there was a gradual increase in the probability of axillary nodal involvement. However, in the group of patients with tumor size smaller than 1 cm, axillary metastasis occurred in 25%. When the axillary nodes were involved, the cure rate in those patients was not significantly better than the rates for those with larger primary tumors in this study. Tumors located in the medial half of the breast were associated with a slightly lower cure rate than those in the lateral half. Young women under 35 years of age had poorer survival and cure rates, although in women 35-44 years of age, the five-year results were comparable to the older group of patients. In blacks, breast cancer was diagnosed in a relatively more advanced stage than in whites. Survival and cure rates were generally lower for blacks, and such lower rates seem to be associated with the relatively advanced stage of the disease.
Similar articles
-
Management and survival of female patients with "minimal" breast cancer: as observed in the long-term and short-term surveys of the American College of Surgeons.Cancer. 1981 Jun 15;47(12):2769-78. doi: 10.1002/1097-0142(19810615)47:12<2769::aid-cncr2820471202>3.0.co;2-7. Cancer. 1981. PMID: 7260868
-
Complete axillary lymph node dissection for stage I-II carcinoma of the breast.J Clin Oncol. 1986 May;4(5):655-62. doi: 10.1200/JCO.1986.4.5.655. J Clin Oncol. 1986. PMID: 3701387
-
Results of treating 1,178 patients with breast cancer by radical mastectomy and postoperative irradiation where metastases to axillary lymph nodes occurred.J Surg Oncol. 1979;12(2):137-53. doi: 10.1002/jso.2930120208. J Surg Oncol. 1979. PMID: 491682
-
Correlation of tumor size and axillary lymph node involvement with prognosis in patients with T1 breast carcinoma.Cancer. 1998 Dec 15;83(12):2502-8. Cancer. 1998. PMID: 9874455 Review.
-
Evolution of axillary nodal staging in breast cancer: clinical implications of the ACOSOG Z0011 trial.Cancer Control. 2012 Oct;19(4):267-76. doi: 10.1177/107327481201900403. Cancer Control. 2012. PMID: 23037494 Review.
Cited by
-
Treatment of primary breast cancer without mastectomy. The Los Angeles community experience and review of the literature.Ann Surg. 1986 Aug;204(2):136-47. Ann Surg. 1986. PMID: 3741005 Free PMC article.
-
Quantitative LC-MS/MS Analysis of Proteins Involved in Metastasis of Breast Cancer.PLoS One. 2015 Jul 15;10(7):e0130760. doi: 10.1371/journal.pone.0130760. eCollection 2015. PLoS One. 2015. PMID: 26176947 Free PMC article.
-
Prognostic value of genomic alterations in minimal residual cancer cells purified from the blood of breast cancer patients.Br J Cancer. 2000 Dec;83(12):1664-73. doi: 10.1054/bjoc.2000.1501. Br J Cancer. 2000. PMID: 11104564 Free PMC article.
-
Utilizing prognostic and predictive factors in breast cancer.Curr Treat Options Oncol. 2005 Mar;6(2):147-59. doi: 10.1007/s11864-005-0022-1. Curr Treat Options Oncol. 2005. PMID: 15717996 Review.
-
The Role of Nodes and Nodal Assessment in Diagnosis, Treatment and Prediction in ER+, Node-Positive Breast Cancer.J Pers Med. 2023 Oct 8;13(10):1476. doi: 10.3390/jpm13101476. J Pers Med. 2023. PMID: 37888087 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Medical